Beta-Eudesmol

CAT:
804-HY-N6018-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Beta-Eudesmol - image 1

Beta-Eudesmol

  • UNSPSC Description:

    Beta-Eudesmol has anticancer and anti-inflammatory activities. Beta-Eudesmol can induce apoptosis. Beta-Eudesmol is a neostigmine antagonist. Beta-Eudesmol can antagonize neostigmine-induced neuromuscular failure. Beta-Eudesmol can be used in the study of sepsis diseases. Beta-Eudesmol is a sesquiterpene-like compound that can be extracted from the rhizome of Atractylodes lancea[1][2][3][4].
  • Target Antigen:

    Caspase; Reactive Oxygen Species; SOD; TNF Receptor
  • Type:

    Natural Products
  • Related Pathways:

    Apoptosis;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Cancer; Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/beta-eudesmol.html
  • Purity:

    96.54
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL
  • Smiles:

    C[C@]12[C@@](C(CCC2)=C)([H])C[C@H](C(C)(O)C)CC1
  • Molecular Weight:

    222.37
  • References & Citations:

    [1]Ma EL,et al. Beta-eudesmol suppresses tumour growth through inhibition of tumour neovascularisation and tumour cell proliferation. J Asian Nat Prod Res. 2008 Jan-Feb;10(1-2):159-67.|[2] Xu Q, et al. Protective effects of β-eudesmol against septic liver injury via inhibition of NF-κB signaling[J]. Tropical Journal of Pharmaceutical Research, 2022, 21(6): 1183-1188.|[3]Chiou LC, et al. Antagonism by beta-eudesmol of neostigmine-induced neuromuscular failure in mouse diaphragms. Eur J Pharmacol. 1992 Jun 5;216(2):199-206.|[4]Hoang D M, et al. Eudesmols induce apoptosis through release of cytochrome c in HL-60 cells[J]. Natural Product Sciences, 2010, 16(2): 88-92.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -20°C (Powder, stored under nitrogen)
  • Clinical Information:

    No Development Reported
  • CAS Number:

    473-15-4